Boehringer Ingelheim confirms that the company’s disclosures of transfers of value (ToVs) to HCPs and HCOs made in 2015 have been reported in application of the EFPIA Disclosure Code key principles. Click here to view the signed self-certification document.
Please find below the links to the transparency websites of Boehringer Ingelheim affiliates in countries with EFPIA member associations. All reports will be published in accordance with local rules by June 30 the latest. The list will be completed after that date.